TY - JOUR
T1 - Breathing fresh air into respiratory research with single-cell rna sequencing
AU - Alexander, Michael J.
AU - Scott Budinger, G. R.
AU - Reyfman, Paul A.
N1 - Funding Information:
Support statement: Funding support was received from ATS Foundation/Boehringer Ingelheim Pharmaceuticals Inc. Research Fellowship in IPF, National Heart, Lung, and Blood Institute (HL071643, K08HL146943, T32HLO76139), National Institute on Aging (AG049665), Parker Foundation (Parker B. Francis Fellowship), and U.S. Department of Veterans Affairs (BX000201). Funding information for this article has been deposited with the Crossref Funder Registry.
Publisher Copyright:
© 2020, European Respiratory Society. All rights reserved.
PY - 2020/6
Y1 - 2020/6
N2 - The complex cellular heterogeneity of the lung poses a unique challenge to researchers in the field. While the use of bulk RNA sequencing has become a ubiquitous technology in systems biology, the technique necessarily averages out individual contributions to the overall transcriptional landscape of a tissue. Single-cell RNA sequencing (scRNA-seq) provides a robust, unbiased survey of the transcriptome comparable to bulk RNA sequencing while preserving information on cellular heterogeneity. In just a few years since this technology was developed, scRNA-seq has already been adopted widely in respiratory research and has contributed to impressive advancements such as the discoveries of the pulmonary ionocyte and of a profibrotic macrophage population in pulmonary fibrosis. In this review, we discuss general technical considerations when considering the use of scRNA-seq and examine how leading investigators have applied the technology to gain novel insights into respiratory biology, from development to disease. In addition, we discuss the evolution of single-cell technologies with a focus on spatial and multi-omics approaches that promise to drive continued innovation in respiratory research.
AB - The complex cellular heterogeneity of the lung poses a unique challenge to researchers in the field. While the use of bulk RNA sequencing has become a ubiquitous technology in systems biology, the technique necessarily averages out individual contributions to the overall transcriptional landscape of a tissue. Single-cell RNA sequencing (scRNA-seq) provides a robust, unbiased survey of the transcriptome comparable to bulk RNA sequencing while preserving information on cellular heterogeneity. In just a few years since this technology was developed, scRNA-seq has already been adopted widely in respiratory research and has contributed to impressive advancements such as the discoveries of the pulmonary ionocyte and of a profibrotic macrophage population in pulmonary fibrosis. In this review, we discuss general technical considerations when considering the use of scRNA-seq and examine how leading investigators have applied the technology to gain novel insights into respiratory biology, from development to disease. In addition, we discuss the evolution of single-cell technologies with a focus on spatial and multi-omics approaches that promise to drive continued innovation in respiratory research.
UR - http://www.scopus.com/inward/record.url?scp=85087471846&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85087471846&partnerID=8YFLogxK
U2 - 10.1183/16000617.0060-2020
DO - 10.1183/16000617.0060-2020
M3 - Review article
C2 - 32620586
AN - SCOPUS:85087471846
SN - 0905-9180
VL - 29
SP - 1
EP - 14
JO - European Respiratory Review
JF - European Respiratory Review
IS - 156
M1 - 200060
ER -